Companies / BOC Sciences / Emapalumab
BOC Sciences

Emapalumab | BOC Sciences

Emapalumab is an anti-interferon-gamma (IFN_) monoclonal antibody approved for the treatment of primary hemophagocytic lymphohistiocytosis (HLH).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.